Edesa Biotech, Inc.EDSANASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P21
Within normal range
vs 3Y Ago
-4.9x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-49.73%
202426.31%
202345.95%
202210.14%
2021-174.05%
2020-2.90%
2019-4.99%
20181.79%
2017-4.31%
2016-2.11%